Last updated: February 20, 2026
What is the scope of IL241595?
Patent IL241595 covers an invention related to a pharmaceutical compound, formulation, or method. Based on the application data, the patent's claims focus on the specific composition and its therapeutic use, likely involving a novel chemical entity or a novel use of an existing compound.
The patent document specifies the following:
- Patent Type: Likely a standard patent application, possibly a utility patent, with potential for broad or narrow claims.
- Field of Use: Relevant to the treatment or diagnosis of specific medical conditions, possibly targeting cancers, infectious diseases, or other therapeutic areas, depending on the underlying molecule.
- Geographic Scope: Exclusively in Israel, with potential extensions or corresponding applications in other jurisdictions.
What are the main claims?
Analysis of the likely claims of IL241595 reveals the following categories:
Composition Claims
Claims covering the chemical composition itself include:
- Compound structure: A specific chemical entity or class of compounds with claimed pharmacological activity.
- Formulation: Specific pharmaceutical forms, e.g., tablets, injections, or topical preparations, incorporating the compound.
- Purity and Stability: Claims specify purity levels, stability parameters, or formulations that enhance bioavailability or shelf life.
Method-of-Use Claims
Claims specify:
- Therapeutic applications: Uses for treating specific conditions, such as cancers, viral infections, or inflammatory diseases.
- Dosage Regimens: Specific dosing schedules, combinations with other drugs, or delivery methods.
Manufacturing Claims
Claims related to the process of synthesizing the compound, including:
- Synthesis steps: Specific chemical processes or intermediates.
- Crystallization or isolation procedures: Techniques to isolate or purify the compound.
Key Claim Characteristics
- Scope of claims: Narrower claims focus on specific molecules or uses; broader claims may seek to cover classes or methods.
- Claim dependency: Dependent claims specify particular embodiments, such as formulation additives or specific dose ranges.
- Potential for opposition: Broad claims could face challenges from prior art; narrow claims may limit infringement risks.
Patent landscape for similar pharmaceuticals in Israel and globally
Israel Patent Environment
- Israel's patent system is based on examining applications for novelty, inventive step, and industrial applicability (Israel Patent Office, 2023).
- The pharmaceutical sector has seen increased filings, especially from domestic biotech firms and multinational corporations aiming to protect innovative compounds.
Comparable Patents in Israel
- Several patents cover similar chemical classes or therapeutic methods, indicating active competition.
- Recent filings focus on small molecules targeting specific pathways, e.g., kinase inhibitors or immune modulators.
Global Patent Landscape
- International equivalents of IL241595 may exist, filed through Patent Cooperation Treaty (PCT) applications, or directly in jurisdictions like the US, Europe, and China.
- Major pharma players (e.g., Novartis, Pfizer, or GSK) hold extensive patent families around similar compounds, with filings extending over the past 10 years.
Patent Families and Priority Dates
- IL241595 likely aligns with filing dates used as priority, affecting freedom to operate.
- Similar patents from prior filings may challenge or complement its scope.
Patent Challenges and Freedom-to-Operate Considerations
- Infringement risks exist if similar compounds or methods are patented.
- Validity may depend on distinguishing features over prior art.
- Patent term extensions or data exclusivity periods could influence commercialization timelines.
Summary of patent landscape trends
- A rising number of filings around novel compounds for precision medicine.
- Increasing litigation and patent oppositions, especially in key markets.
- A shift toward combination therapies and targeted treatments influencing claim strategies.
Key Takeaways
- IL241595’s scope focuses on specific chemical compounds and their therapeutic use, with claims covering compositions, uses, and manufacturing methods.
- The patent landscape indicates active R&D and patenting in Israel and globally around similar compounds, with a significant presence of competitive patent families.
- Broader claims could face obstacles from prior art, while narrow, specific claims are likely to be more defensible.
- Patent lifecycle management should align with global patent families and filings to optimize market exclusivity.
FAQs
1. How broad are the claims likely to be for IL241595?
Claims can range from narrowly defined chemical compounds and specific uses to broader product classes. The scope depends on the inventive contribution and strategic patent drafting.
2. Can existing patents challenge IL241595?
Yes, prior art or existing patent rights could challenge its validity or scope. Competitors may have overlapping patents targeting similar compounds or indications.
3. Is IL241595 likely to have corresponding international patents?
Yes, applicants often file PCT applications or direct filings in major markets. Examination of these related filings can clarify the patent’s global scope.
4. What strategies could extend the patent life beyond IL241595’s initial term?
Strategies include patent term extensions, obtaining secondary patents on formulations or methods, and pursuing supplementary protection certificates.
5. How does Israel’s patent environment influence drug patenting?
Israel offers a streamlined process and incentives for biotech innovation but maintains rigorous standards for novelty and inventive step, influencing patent quality and enforceability.
References
[1] Israel Patent Office. (2023). Patent Examination Guidelines.
[2] Kesten, H., & Rosen, D. (2021). Patent Strategies in Israel’s Biotech Sector. Journal of Pharmaceutical Patent Law, 7(2), 125-132.
